^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    PredicineCNB™

    Company:
    Predicine
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    PredicineCNB is a companion LP-WGS assay to robustly estimate genome-wide copy number burden (CNB) from plasma and urine clinical samples, which can provide longitudinal disease monitoring in a cost-effective way. A comprehensive clinical study using PredicineCNB in 1,000 patients with prostate and bladder cancers demonstrated the promising clinical application of liquid biopsy-based genome-wide copy number changes in therapy monitoring.
    Cancer:
    Bladder Cancer, Prostate Cancer
    Method:
    Low-pass whole-genome sequencing